According to the Complaint, India Globalization Capital, Inc. (“IGC” or the Company) operates two distinct business segments. One segment develops and commercializes cannabinoid based alternative therapies for indications such as Alzheimer’sdisease, Parkinson’s disease, and pain. The Company’s second segment, operated since its inception, is a legacy business that involves trading commodities and heavy equipment rental.
We use cookies to improve your overall web experience. By using our website, you consent to the use of cookies in accordance with our Privacy Policy.